Streetbeat News

TNON

Tenon Medical, Inc.

https://www.tenonmed.com

Industry

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Open

2.69

Mkt cap

8.5M

Volume

145K

High

2.77

P/E Ratio

-0.10

52-wk high

20.00

Low

2.61

Div yield

N/A

52-wk low

2.61

Tenon Medical has received a Notice of Allowance for a U.S. patent on its systems and methods for stabilizing sacroiliac joints. This development could enhance its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 2:33 pm

Trading for TNON was halted and has now resumed as of 8:55 AM ET. This update is crucial for investors tracking the stock's movements.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:55 pm

Trading for TNON has been halted as of 7:50:00 p.m. ET due to pending news. Investors should stay alert for updates that could impact the stock's price.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:50 pm

Tenon Medical has announced the first publication of the MAINSAIL study, which evaluates the effectiveness of the Catamaran SI Joint Fusion System in treating adult patients with sacroiliac joint disruptions or degenerative sacroiliitis.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:37 am

Tenon Medical has appointed Kevin Williamson as the new Chief Financial Officer, succeeding Steve Van Dick, who is retiring.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:10 pm

Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Tenon Medical (NASDAQ:TNON) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 2:28 pm

Tenon Medical shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 2:28 pm

Tenon Medical (NASDAQ:TNON) reported Q2 2024 GAAP EPS of $(1.02), beating the estimate of $(1.08). However, sales of $901K missed the $909.5K estimate. Sales increased by 21.27% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:14 pm

Ainos, Inc. (NASDAQ:AIMD) shares surged 37.7% in pre-market trading after securing exclusive licenses for 10 patents from Taiwan Carbon Nano Technology. Other notable pre-market movers include LogicMark, Inc. (NASDAQ:LGMK) up 49% following a $4.5 million public offering, and Meta Materials Inc. (NASDAQ:MMAT) down 27.7% after filing for Chapter 7 bankruptcy.

Portfolio Pulse from Avi Kapoor

August 12, 2024 | 10:04 am

The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include Qualigen Therapeutics (QLGN), Sharps Technology (STSS), and Autonomix Medical (AMIX), while Reshape Lifesciences (RSLS) and CNS Pharma (CNSP) were among the losers.

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 3:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.